Shattuck Labs, Inc. is a clinical-stage biotechnology company based in Austin, Texas, focused on advancing innovative therapies for cancer and autoimmune diseases. Leveraging its proprietary technology platforms, the company is dedicated to developing targeted treatments aimed at addressing significant unmet medical needs. With a strong commitment to research and development, Shattuck Labs is positioned to make impactful contributions to the biopharmaceutical industry, aiming to improve patient outcomes through its next-generation therapeutics.